Abrysvo
Respiratory Syncytial Virus Vaccine
Listed by Pfizer Laboratories Div Pfizer Inc
- Strength
- .06 mg/.5mL, .06 mg/.5mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intramuscular
What it contains
- Recombinant Stabilized Rsv A Prefusion F Antigen .06 mg/.5mL
- Recombinant Stabilized Rsv B Prefusion F Antigen .06 mg/.5mL
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intramuscular |
| Approval route | BLA — biologic licence |
| NDC code | 0069-2465 |
| FDA application | BLA125769 |
| Package sizes listed | 2 |
| Marketed since | July 2024 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.